OBN Appoints Chair
This article was originally published in Scrip
OBN, the organization supporting UK's life sciences companies, has appointed Sally Waterman chair of OBN – effective immediately. Waterman succeeds David Laskow-Pooley who stepped down as chair after eight years and will continue as a non-executive director of OBN. Waterman joined OBN's board as a non-executive director in 2014 and is currently the senior vice president of corporate development at Abzena Plc.